Skip to content
PubMed This is a summary of 9 peer-reviewed journal articles Updated
Pediatric Gastroenterology

Managing Balance: Treatment and Daily Care for CSD

At a Glance

Congenital sodium diarrhea is managed by replacing ongoing sodium, bicarbonate, and fluid losses rather than trying to stop diarrhea. Children may need individualized IV fluids, nutrition through a central line, gradual enteral feeding, oral supplements, and close specialist monitoring at home.

The primary goal of managing Congenital Sodium Diarrhea (CSD) is not to “stop” the diarrhea, but to replace exactly what is being lost. Because your child’s body cannot hold onto sodium and water, treatment focuses on a careful, daily balance of fluid and electrolyte replacement to support growth and brain development [1][2][3].

The Foundation of Care: Fluid Replacement

In the beginning, your child will likely need separately prescribed IV fluids and electrolytes, alongside Parenteral Nutrition (PN), which provides nutritional support directly into the bloodstream through a central line [1][4].

  • Replacing Sodium and Bicarbonate: Because CSD causes the body to lose sodium and bicarbonate (which balances acid in the blood), these must be carefully replaced [3][2].
  • Frequent Adjustments: In the NICU, doctors will check your baby’s blood and stool chemistry frequently. They use these numbers to adjust the individualized “recipe” of the IV fluids or feeds to keep the body’s chemistry stable [2][1].
  • Clinician-Directed Replacement: A key part of CSD care is managing the “output” (stool) with the “input” (fluids). Replacement is individualized and must account for maintenance needs, insensible losses, renal function, and laboratory values. Caregivers should never alter fluid, sodium, bicarbonate, or PN prescriptions without their specialist’s written plan.

Transitioning to Enteral Feeding

As your child stabilizes, the medical team will gradually begin enteral feeds—nutrition given through a feeding tube or by mouth. This process is slow and highly individualized.

  • The Goal of Enteral Autonomy: This is the term for being able to get all the fluids and nutrients the body needs without an IV line (PN) [5]. Coming off PN does not automatically mean that stool losses no longer need monitoring or supplementation.
  • Success Stories: While some children with severe or syndromic (SPINT2) forms of CSD may need PN for a long time, others—particularly those with certain GUCY2C or SLC9A3 mutations—have been reported to successfully transition to full enteral feeds [2][5][6].
  • Formula Selection: While no single formula is proven to be “best” for CSD, some doctors use specialized amino-acid or hydrolyzed formulas to make digestion as easy as possible for the child’s gut, though this does not fix the underlying genetic transport defect [2].

Managing CSD at Home

Going home with CSD involves a structured maintenance plan. You will essentially become part of the medical team, managing your child’s daily electrolyte and fluid needs.

  • Oral Supplements: Most children who transition off PN will still need oral sodium and bicarbonate supplements. These are prescribed to replace ongoing stool losses [3][2].
  • Central Line Safety: Long-term PN carries major safety issues, including catheter-associated bloodstream infection, thrombosis, accidental dislodgment, and intestinal-failure-associated liver disease. You must receive line-care teaching, a written contact pathway, and explicit instructions for what to do during fever, redness, or pump failure.
  • Growth as a Guide: The best sign that the treatment plan is working is that your child is growing and gaining weight appropriately for their age [3][7].
  • Intestinal Rehabilitation: Many families work with a specialized “Intestinal Rehab” team. These experts focus on maximizing the gut’s ability to absorb nutrients while minimizing the complications of long-term IV or tube feeding [2][8].

A Note on Medications

Currently, there are no approved CSD-specific therapies that “cure” or significantly stop the diarrhea in CSD.

  • Standard Antidiarrheals: Common medications used for typical diarrhea often do not work for CSD. Caregivers should not start over-the-counter antidiarrheals or antisecretory drugs without the treating team [1][9].
  • Off-Label Therapies: You may hear about medications like crofelemer. It is approved for a different adult indication but has limited/off-label evidence in CSD. Its pediatric use requires specialist oversight [8]. Decisions about these medications are made on a case-by-case basis by specialized gastroenterologists.

Common questions in this guide

What is the main treatment for congenital sodium diarrhea?
The main treatment is carefully replacing the sodium, bicarbonate, and fluid lost in stool rather than trying to stop the diarrhea. Infants may initially need individualized IV fluids and nutrition through a central line, with adjustments based on blood tests, stool losses, kidney function, and growth.
Can a child with CSD eventually stop parenteral nutrition?
Some children can gradually reach enteral autonomy, meaning they get all fluids and nutrients by mouth or feeding tube, while others, especially those with severe or syndromic disease, need parenteral nutrition longer. The transition must be slow and supervised, and coming off parenteral nutrition does not eliminate the need to monitor stool losses or use supplements.
What formula is recommended for a child with CSD?
There is no single formula proven to be best for congenital sodium diarrhea. A specialist may recommend an amino-acid or hydrolyzed formula to make digestion easier, but formula does not correct the underlying intestinal transport problem.
What does home treatment for CSD involve?
Home care may include prescribed oral sodium and bicarbonate, recording weight, urine and stool output, and temperature, and following a written plan for feeds and fluids. Caregivers should not change the amounts or recipe without the specialist team’s instructions.
How can we keep a central line safe during CSD treatment?
Families need hands-on training for line care, pump troubleshooting, and a clear after-hours contact plan. Fever, redness around the line, accidental dislodgment, or pump failure should be handled according to the team’s urgent instructions because long-term IV nutrition can cause serious complications.
Do diarrhea medicines work for congenital sodium diarrhea?
Common over-the-counter antidiarrheal or antisecretory medicines often do not work for CSD and should not be started without the treating team. Crofelemer has only limited off-label evidence in CSD, and any use in a child requires specialist supervision.

Get notified when new evidence is published on Congenital sodium diarrhea.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (9)
  1. 1

    Congenital sodium diarrhoea caused by rare de novo activating guanylate cyclase mutation.

    Bajracharya S, Stich D, Berman J, Biank V

    BMJ case reports 2022; (15(12)) doi:10.1136/bcr-2022-251632.

    PMID: 36581358
  2. 2

    Successful therapy for congenital sodium diarrhea by enteral management: A case report.

    Thorvilson DA, Skiba CC, Muzzy JD, et al.

    Nutrition (Burbank, Los Angeles County, Calif.) 2023; (114()):112096 doi:10.1016/j.nut.2023.112096.

    PMID: 37399692
  3. 3

    Congenital Sodium Diarrhea by mutation of the SLC9A3 gene.

    Dimitrov G, Bamberger S, Navard C, et al.

    European journal of medical genetics 2019; (62(10)):103712 doi:10.1016/j.ejmg.2019.103712.

    PMID: 31276831
  4. 4

    Approach to Congenital Diarrhea and Enteropathies (CODEs).

    Kijmassuwan T, Balouch F

    Indian journal of pediatrics 2024; (91(6)):598-605 doi:10.1007/s12098-023-04929-7.

    PMID: 38105403
  5. 5

    De novo activating GUCY2C variant with prenatal bowel dilatation, neonatal functional obstruction, and reversible intestinal failure: A case report.

    Cantagalli MM, Amato T, Chioccioli S, et al.

    Intestinal Failure (New York, N.Y.) 2026; (11()):100376 doi:10.1016/j.intf.2026.100376.

    PMID: 42318326
  6. 6

    Syndromic congenital diarrhoea: new SPINT2 mutation identified in the UAE.

    Bou Chaaya S, Eason JD, Ofoegbu BN

    BMJ case reports 2017; (2017()) doi:10.1136/bcr-2016-217464.

    PMID: 28716867
  7. 7

    Further delineation of SLC9A3-related congenital sodium diarrhea.

    Bogdanic E, Müller T, Heinz-Erian P, et al.

    Molecular genetics & genomic medicine 2022; (10(8)):e2000 doi:10.1002/mgg3.2000.

    PMID: 35775128
  8. 8

    Clinical course and therapeutic trial for a case of congenital secretory diarrhea due to novel GUCY2C variant.

    Scott W, Wong IGY, Cramer J, et al.

    American journal of medical genetics. Part A 2024; (194(4)):e63489 doi:10.1002/ajmg.a.63489.

    PMID: 38058249
  9. 9

    Secretory Diarrhea Caused by Activating GUCY2C Mutation in a Patient With Atypical Kawasaki Disease: A Rare Case Report.

    Mujahed R, Banat MA, Jawabreh M, et al.

    Sage open pediatrics 2025; (12()):30502225251403777 doi:10.1177/30502225251403777.

    PMID: 41467067

This page is for informational purposes only and does not constitute medical advice. Fluid, electrolyte, feeding, and medication plans for a child with congenital sodium diarrhea must be prescribed and adjusted by the treating specialist team.